Next, LA was tested in a cellular HIV-1/HSV-2-co-infection model and its antiviral activity was compared with the well-known HIV-1 entry inhibitor AMD3100 (a CXCR4 antagonist) and the HSV-2 DNA polymerase inhibitor acyclovir. The gene discussed is CXCR4; the disease is coinfection.